Search This Blog

Thursday, August 8, 2019

Dicerna Pharmaceuticals EPS misses by $0.04, misses on revenue

Dicerna Pharmaceuticals (NASDAQ:DRNA): Q2 GAAP EPS of -$0.35 misses by $0.04.
Revenue of $5.68M (+268.8% Y/Y) misses by $6.07M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)